ID   GM12244
AC   CVCL_5D29
AS   CVCL_G547
SY   CEPH-1416-NA12244; 1416-1191
DR   CLO; CLO_0019224
DR   Coriell; GM12244
DR   dbMHC; 48709
DR   GEO; GSM660031
DR   GEO; GSM660238
DR   GEO; GSM660442
DR   IHW; IHW01178
DR   IPD-IMGT/HLA; 25970
DR   Wikidata; Q54845628
RX   PubMed=14583597;
RX   PubMed=20889555;
RX   PubMed=29959025;
WW   https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141607.
CC   HLA typing: A*02:01,23:01; B*15:01,41:01; C*03:03,17:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*02:01,03:01; DQB1*02:01,03:02:01; DRB1*04:01,07:01 (IPD-IMGT/HLA=25970).
CC   HLA typing: A*02:01:01,23:01:01; B*15:01:01,41:01:01; C*03:03:01,17:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*02:01:01,03:01:01; DQB1*02:02:01,03:02:01; DRB1*04:01:01,07:01:01; DRB4*01:03:01,01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 17
//
RX   PubMed=14583597; DOI=10.1152/physiolgenomics.00163.2003;
RA   Pastinen T., Sladek R., Gurd S., Sammak A., Ge B., Lepage P.,
RA   Lavergne K., Villeneuve A., Gaudin T., Brandstrom H., Beck A.,
RA   Verner A., Kingsley J., Harmsen E., Labuda D., Morgan K., Vohl M.-C.,
RA   Naumova A.K., Sinnett D., Hudson T.J.;
RT   "A survey of genetic and epigenetic variation affecting human gene
RT   expression.";
RL   Physiol. Genomics 16:184-193(2004).
//
RX   PubMed=20889555; DOI=10.2353/jmoldx.2010.100090;
RA   Pratt V.M., Zehnbauer B.A., Wilson J.A., Epstein-Baak R., Babic N.,
RA   Bettinotti M.P., Buller-Burckle A.M., Butz K.G., Campbell M.,
RA   Civalier C., El-Badry A., Farkas D.H., Lyon E., Mandal S., McKinney J.,
RA   Muralidharan K., Noll L., Sander T., Shabbeer J., Smith C.-Y.H.,
RA   Telatar M., Toji L.H., Vairavan A., Vance C., Weck K.E., Wu A.H.B.,
RA   Yeo K.-T.J., Zeller M., Kalman L.V.;
RT   "Characterization of 107 genomic DNA reference materials for CYP2D6,
RT   CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for
RT   Molecular Pathology collaborative project.";
RL   J. Mol. Diagn. 12:835-846(2010).
//
RX   PubMed=29959025; DOI=10.1016/j.jmoldx.2018.05.009;
RA   Bettinotti M.P., Ferriola D., Duke J.L., Mosbruger T.L., Tairis N.,
RA   Jennings L., Kalman L.V., Monos D.S.;
RT   "Characterization of 108 genomic DNA reference materials for 11 human
RT   leukocyte antigen loci: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 20:703-715(2018).
//